PADCEV (enfortumab vedotin-ejfv)

20 mg intravenous solution

• Infuse 1.25 mg/kg (not to exceed 125 mg) over 30 minute(s) by intravenous route on days 1, 8 and 15 of a 28 day cycle

30 mg intravenous solution

• Infuse 1.25 mg/kg (not to exceed 125 mg) over 30 minute(s) by intravenous route on days 1, 8 and 15 of a 28 day cycle

Transitional cell carcinoma of the urinary tract

• Infuse 1.25 mg/kg (not to exceed 125 mg) over 30 minute(s) by intravenous route on days 1, 8 and 15 of a 28 day cycle

• Infuse 1 mg/kg (not to exceed 100 mg) over 30 minute(s) by intravenous route on days 1, 8 and 15 of a 28 day cycle

• Infuse 0.75 mg/kg (not to exceed 75 mg) over 30 minute(s) by intravenous route on days 1, 8 and 15 of a 28 day cycle

• Infuse 0.5 mg/kg (not to exceed 50 mg) over 30 minute(s) by intravenous route on days 1, 8 and 15 of a 28 day cycle